Phase I and pharmacologic studies of topotecan in patients with impaired hepatic function.
O'Reilly S, Rowinsky E, Slichenmyer W, Donehower RC, Forastiere A, Ettinger D, Chen TL, Sartorius S, Bowling K, Smith J, Brubaker A, Lubejko B, Ignacio V, Grochow LB.
O'Reilly S, et al. Among authors: lubejko b.
J Natl Cancer Inst. 1996 Jun 19;88(12):817-24. doi: 10.1093/jnci/88.12.817.
J Natl Cancer Inst. 1996.
PMID: 8637048
Clinical Trial.